Star Combo Pharma Ltd (ASX: S66) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Star Combo Pharma Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $15.53 million
P/E Ratio 21.82
Dividend Yield 3.08%
Shares Outstanding 135.08 million
Earnings per share 0.006
Dividend per share 0.00
Year To Date Return -14.69%
Earnings Yield 4.58%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Star Combo Pharma Ltd (ASX: S66)
    Latest News

    No posts found.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    14 Oct 2024 $0.0037 100.00% Final 31 Oct 2024

    S66 ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Star Combo Pharma Ltd

    Star Combo Pharma Ltd is engaged in the manufacturing and distribution of food products and nutritional supplements. The company offers products such as face masks, moisturizing creams, serums, concentrates, and oils. Star Combo Pharma markets its products. It operates in two segments. Star Combo segment engages in the development, manufacturing, marketing and sales of natural health supplements and skincare products. The Austoyou retail business segment has made up of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers; and Koala Mall's two retail stores in Sydney. Geographically, it operates in China and Australia.

    S66 Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    25 Nov 2024 $0.12 $0.00 0.00% 1,921 $0.12 $0.12 $0.12
    20 Nov 2024 $0.12 $0.00 0.00% 351 $0.12 $0.12 $0.12
    18 Nov 2024 $0.12 $0.00 0.00% 65,375 $0.12 $0.12 $0.12
    14 Nov 2024 $0.12 $0.01 9.09% 31,818 $0.13 $0.13 $0.12
    11 Nov 2024 $0.11 $-0.02 -15.38% 124,727 $0.12 $0.12 $0.11
    06 Nov 2024 $0.13 $-0.02 -13.33% 150,000 $0.14 $0.14 $0.13

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Richard Ivan Allely Non-Executive ChairmanNon-Executive Director Feb 2018
    Mr Allely has previously held non-executive roles on the boards of Australian Medical Publishing Company Pty Ltd, Perisher Blue Pty Ltd, Australian Property Monitors Pty Ltd and Source Financial Inc. (a USA Public Company). He has also been an independent member of Work Cover Authority of NSW and an advisory board member of Renoir Consulting Group. Richard was the Managing Director and CEO of PMP Ltd (PMP) until 2012, when he stepped down from the position, after serving just over 10 years with the company (seven years as CFO). Prior to this, Richard held senior executive roles with a number of leading Australian and International companies including Tenix Pty Ltd (formerly Transfield Pty Ltd), John Fairfax Holdings Ltd, Boral Ltd, James Hardie Industries Ltd and Fanner-PLP Pty Ltd. Richard has experience in the manufacturing, building and construction, and publication and media sectors within Australia and Southeast Asia.
    Ms Su Zhang Chief Executive OfficerExecutive DirectorJoint Company Secretary Nov 2016
    Ms Zhang has been working in the pharmaceutical industry for over 10 years, starting her career with Terry White Chemists. Upon leaving Terry White Chemists, Su worked for three years at Abbott Australia. She commenced at Abbott Australia as a Senior Drug Safety Associate and later moved into the role of Asia Pacific Regional Manager. In 2009, Su commenced employment with Star Combo, initially focusing her efforts on obtaining a TGA license for Costar Pharma. Su's responsibilities within Star Combo include quality control and compliance, operational management, production planning and sales cycle management.
    Mr Star (JinXing) Zhang Managing Director Nov 2016
    Mr Zhang is the founder of Star Combo and has a background in the pharmaceutical industry. After graduation from university, Star worked for 10 years at a medical research company in China which produced hard gel capsules, tablets and injections. While there, he pioneered the extraction and purification of hyaluronic acid, important as a lubricant in ocular surgery. Furthermore, he developed methods to separate low molecular weight hyaluronic acid, which is used in cosmetics. Star then immigrated to New Zealand, where he studied Commerce at the University of Auckland for one year. Upon returning to Australia, Star incorporated Star Combo in 2004 to address the need for high quality and affordable Australian-made health foods in the market.
    Ms Wei Han Non-Executive Director May 2020
    Ms Han has knowledge and experience in company governance of a listed company, compliance and financial management. Prior to joining Goldenmax International, Ms. Han has more than 30 years of specialised experience in company governance and accounting, providing professional services in the Chinese food and consumer industry.
    Mr Jialong Ding Non-Executive Director May 2020
    Mr Ding has over 30 years of experience in pharmaceutical distribution, production, and compliance. Prior to this, Mr. Ding held senior executive roles in several Chinese pharmaceutical companies, including subsidiaries of Shanghai Pharma. Mr. Ding was Vice President of China Nonprescription Medicines Association (CNMA) and Vice President of Shanghai Pharmaceutical Profession Association (SPPA).
    Mr Patrick Raper Company Secretary Oct 2018
    -
    Mr James Ni Chief Financial Officer
    -
    Patrick Raper Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Goldenstar Pharmaceutical Investment Limited 49,000,000 36.27%
    Jinxing(Star) Zhang 38,165,510 28.25%
    Miss Su Zhang 11,448,980 8.48%
    Lepu Medical (Europe) Cooperatief U.A. 11,000,000 8.14%
    Certane Ct Pty Ltd 3,541,178 2.62%
    Mr Liang Zuo 2,243,512 1.66%
    Dw & Rl Pty Ltd 2,163,335 1.60%
    Mr Jixiang Shi 1,880,000 1.39%
    Dw & Rl Pty Ltd i 1,270,934 0.94%
    Icomoon Pty Ltd 1,202,090 0.89%
    Eureka Technology Innovation & Investment Pty Ltd 623,000 0.46%
    Mr Brian Albert Donnelly 507,658 0.38%
    Thi Uyen Phuong Nguyen 500,000 0.37%
    Mrs Yun Cong Ye 490,000 0.36%
    Mr Steve Hou 472,238 0.35%
    Ms Lisha Huang 455,000 0.34%
    Mr Huilin Lu 381,681 0.28%
    Paul Thomas Hutchinson 360,000 0.27%
    Mr Xing Kang Jin 349,000 0.26%
    Mr Pisan Chowvalit 343,727 0.26%

    Profile

    since

    Note